RICHESSE™ Glam Fill Body Contouring Filler (1 x 60 mL / 60cc) | JDBIO (South Korea)
Short Description
An advanced, high-capacity monophasic Hyaluronic Acid body filler formulated with 24 mg/mL of pure, non-animal cross-linked HA utilizing patented PNET (Preserved Natural Entanglement Technology). Packaged in an economical 60 mL (60cc) sterile glass vial, RICHESSE™ Glam Fill is engineered for deep subcutaneous and supra-fascial placement to deliver high lifting capacity ($G’$), smooth tissue integration, and durable shape retention for non-surgical gluteal enhancement, hip dip correction, lower-limb sculpting, and post-liposuction contour restoration lasting 12 to 18+ months.
Detailed Description
RICHESSE™ Glam Fill 60 mL is an advanced, sterile, non-pyrogenic physiological cross-linked sodium hyaluronate injectable manufactured in South Korea by JDBIO Co., Ltd. Formulated specifically for large-scale non-surgical body augmentation and soft-tissue remodeling, it provides aesthetic clinicians with the physical volume and viscoelastic projection required to sculpt substantial anatomical zones without surgical implants or autologous fat harvesting.
Synthesized from medical-grade, non-animal bio-fermented hyaluronic acid, RICHESSE Glam Fill is developed using PNET (Preserved Natural Entanglement Technology). Unlike conventional aggressive cross-linking protocols, PNET preserves the natural intermolecular entanglement of the high-molecular-weight HA chains while introducing only a minimal number of synthetic BDDE bonds (yielding a very low Degree of Modification, MoD). This creates a smooth, cohesive monophasic hydrogel with high mechanical lifting capacity ($G’$) and viscosity. When deposited in deep anatomical compartments, the hydrogel resists deformation, compression, and shear stress from continuous body motion (such as the gluteus maximus, tensor fasciae latae, and quadriceps) without flattening, spreading laterally, or migrating into neighboring fascial planes.
Subjected to exhaustive multi-stage dialysis washing, residual BDDE cross-linker is reduced to virtually non-detectable levels (< 0.2 ppm) and endotoxins are kept well below international pharmacopeial limits (< 0.005 EU/mL). The resulting hydrogel delivers high biocompatibility, minimal post-procedure swelling, and rapid patient recovery. Packaged in a 60 mL vial presentation, it provides maximum procedural efficiency and clinic economics for large-area body protocols.
Treatment Areas & Indications
-
Gluteal Augmentation & Buttock Reshaping:
-
Non-surgical buttock projection, upper-pole fullness, and roundness enhancement
-
Correction of lateral gluteal depression, volume deflation, and post-weight-loss laxity
-
-
Lateral Pelvic Contouring & Hip Dip Correction:
-
Smoothing and effacement of lateral pelvic hollows (trochanteric depressions / hip dips)
-
Harmonization of the waist-to-hip silhouette
-
-
Lower Extremity Sculpting & Leg Symmetry:
-
Calf volume enhancement, medial/lateral sculpting, and lower-leg curvature correction
-
Correction of soft-tissue asymmetries between the lower limbs
-
-
Post-Surgical Defect Correction & Soft-Tissue Alignment:
-
Smoothing of post-liposuction contour irregularities, divots, and cannula track depressions
-
Reconstruction of traumatic atrophic indentations and localized deep lipoatrophy
-
Key Clinical Advantages
-
Generous 60 mL (60cc) Presentation: Specifically packaged in a sterile vial for large-volume body indications, drastically reducing cost-per-mL and eliminating the operational complexity of handling dozens of individual 1.0 mL syringes.
-
Patented PNET Cross-Linking Technology: Preserves native HA chain entanglement with minimal chemical modification, delivering natural soft-gel flexibility combined with strong lifting power ($G’$).
-
Ultra-Low BDDE (< 0.2 ppm) & Endotoxin (< 0.005 EU/mL): Exceeds global purity standards, significantly reducing the risk of delayed hypersensitivity, sterile abscesses, and post-injection inflammatory edema.
-
Cohesive Resistance to Lateral Migration: High cohesive density anchors the gel at the targeted anatomical plane, preventing horizontal dispersion into unintended fascial or adipose compartments.
-
100% Biocompatible & Reversible: Formulated from pure HA that integrates cleanly into tissue and can be fully dissolved enzymatically with hyaluronidase if adjustment or reversal is necessary.
-
Smooth Blunt-Cannula Delivery: Despite its 24 mg/mL concentration, the monophasic hydrogel glides evenly through 16G–18G body microcannulas, ensuring continuous extrusion force and uniform retrograde fanning across broad tissue planes.
-
Extended Clinical Durability: Dense molecular entanglement and high total mass resist enzymatic breakdown, sustaining aesthetic contour correction for 12 to 18+ months (and up to 24 months with periodic maintenance touch-ups).
Technical Specifications
| Parameter | Specification |
| Active Substance | Cross-linked Sodium Hyaluronate (non-animal bio-fermentation) |
| HA Concentration | 24 mg/mL |
| Cross-Linking Technology | PNET (Preserved Natural Entanglement Technology, BDDE-based) |
| Cross-Linker Residue (BDDE) | < 0.2 ppm |
| Endotoxin Level | |
| < 0.005 EU/mL | Gel Structure | Advanced Monophasic Hydrogel | Lidocaine Content | Lidocaine-Free (can be blended with local anesthetic/sterile saline per clinic protocol) | Packaging Presentation | 1 x 60 mL (60cc) sterile glass vial | Target Injection Plane | Deep subcutaneous adipose layer or supra-fascial plane | Recommended Injection Tools | 16G / 18G blunt-tip body microcannulas (100–150 mm length) | Recommended Injection Techniques | Retrograde linear fanning, criss-cross tunneling, and multi-planar subcutaneous deposition | Expected Clinical Duration | 12 to 18+ months (up to 24 months with maintenance sessions) | Storage Instructions | Store between 2°C to 25°C (36°F to 77°F); protect from direct sunlight and freezing | Manufacturer / Origin | JDBIO Co., Ltd. |
| (South Korea) | Regulatory Category | Medical Device / CE-certified / Prescription Only (Rx) |
Professional Advisory: RICHESSE™ Glam Fill 60 mL is a high-volume medical body filler intended strictly for certified plastic surgeons, dermatologists, and credentialed aesthetic physicians trained in large-bore blunt-cannula body contouring, deep fascial anatomy, and vascular safety protocols. Injection into the breast parenchyma (glandular tissue), face, glabella, periorbital zone, or superficial intradermal layer is strictly contraindicated.






Reviews
There are no reviews yet.